181 related articles for article (PubMed ID: 37511044)
1. Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma.
Peixoto J; Príncipe C; Pestana A; Osório H; Pinto MT; Prazeres H; Soares P; Lima RT
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511044
[No Abstract] [Full Text] [Related]
2. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization.
Fierro J; DiPasquale J; Perez J; Chin B; Chokpapone Y; Tran AM; Holden A; Factoriza C; Sivagnanakumar N; Aguilar R; Mazal S; Lopez M; Dou H
Sci Rep; 2022 Feb; 12(1):2417. PubMed ID: 35165339
[TBL] [Abstract][Full Text] [Related]
3. A simple and highly efficient method for multi-allelic CRISPR-Cas9 editing in primary cell cultures.
Hoellerbauer P; Kufeld M; Arora S; Wu HJ; Feldman HM; Paddison PJ
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1269. PubMed ID: 32721120
[TBL] [Abstract][Full Text] [Related]
4. Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.
Al-Sammarraie N; Ray SK
Cells; 2021 Sep; 10(9):. PubMed ID: 34571991
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy.
Zou Y; Sun X; Yang Q; Zheng M; Shimoni O; Ruan W; Wang Y; Zhang D; Yin J; Huang X; Tao W; Park JB; Liang XJ; Leong KW; Shi B
Sci Adv; 2022 Apr; 8(16):eabm8011. PubMed ID: 35442747
[TBL] [Abstract][Full Text] [Related]
6. [ADRB2 Gene Knockout in Human Primary T Cells by Multiple sgRNAs Construced using CRISPR/Cas9 Technology].
Sun Y; Liu D; Shi M; Zheng JN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1682-1690. PubMed ID: 31607332
[TBL] [Abstract][Full Text] [Related]
7. Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy.
Ruan W; Jiao M; Xu S; Ismail M; Xie X; An Y; Guo H; Qian R; Shi B; Zheng M
J Control Release; 2022 Nov; 351():739-751. PubMed ID: 36174804
[TBL] [Abstract][Full Text] [Related]
8. Conditional editing of the
Wang BZ; Zhang C; Zhang JL; Sun J
Yi Chuan; 2023 Jul; 45(7):593-601. PubMed ID: 37503583
[TBL] [Abstract][Full Text] [Related]
9. Single Molecule FRET Analysis of CRISPR Cas9 Single Guide RNA Folding Dynamics.
Okafor IC; Ha T
J Phys Chem B; 2023 Jan; 127(1):45-51. PubMed ID: 36563314
[TBL] [Abstract][Full Text] [Related]
10. Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma.
Liu X; Cao Z; Wang W; Zou C; Wang Y; Pan L; Jia B; Zhang K; Zhang W; Li W; Hao Q; Zhang Y; Zhang W; Xue X; Lin W; Li M; Gu J
ACS Nano; 2023 Sep; 17(17):16432-16447. PubMed ID: 37646615
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing
Hamada T; Yokoyama S; Akahane T; Matsuo K; Tanimoto A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613947
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-based CRISPR-Cas9 system efficacy for introducing targeted mutations in CD81 gene of MDA-MB-231 cell line.
Arbabi Zaboli K; Rahimi H; Thekkiniath J; Taromchi AH; Kaboli S
Folia Histochem Cytobiol; 2022; 60(1):13-23. PubMed ID: 35157300
[TBL] [Abstract][Full Text] [Related]
13. Multiplex Single-Nucleotide Microbial Genome Editing Achieved by CRISPR-Cas9 Using 5'-End-Truncated sgRNAs.
Lim SR; Lee HJ; Kim HJ; Lee SJ
ACS Synth Biol; 2023 Jul; 12(7):2203-2207. PubMed ID: 37368988
[TBL] [Abstract][Full Text] [Related]
14. Engineering Citrobacter freundii using CRISPR/Cas9 system.
Alfaro T; Elmore JR; Stromberg ZR; Hutchison JR; Hess BM
J Microbiol Methods; 2022 Sep; 200():106533. PubMed ID: 35779647
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs.
Lee HJ; Kim HJ; Lee SJ
Genome Res; 2020 May; 30(5):768-775. PubMed ID: 32327447
[TBL] [Abstract][Full Text] [Related]
16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
17. LRP1B deletion is associated with poor outcome for glioblastoma patients.
Tabouret E; Labussière M; Alentorn A; Schmitt Y; Marie Y; Sanson M
J Neurol Sci; 2015 Nov; 358(1-2):440-3. PubMed ID: 26428308
[TBL] [Abstract][Full Text] [Related]
18. An efficient CRISPR/Cas9 platform for targeted genome editing in rose (Rosa hybrida).
Wang C; Li Y; Wang N; Yu Q; Li Y; Gao J; Zhou X; Ma N
J Integr Plant Biol; 2023 Apr; 65(4):895-899. PubMed ID: 36460630
[TBL] [Abstract][Full Text] [Related]
19. Interrogation of human microglial phagocytosis by CRISPR genome editing.
Chang JC; Wang CY; Lin S
Front Immunol; 2023; 14():1169725. PubMed ID: 37483607
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
